Profile data is unavailable for this security.
About the company
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company's products are mainly used for the detection of allergic and autoimmune diseases, and the test reagents it produces are used for the clinical auxiliary diagnosis of allergic and autoimmune diseases. The detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others.
- Revenue in CNY (TTM)387.48m
- Net income in CNY36.43m
- Incorporated2009
- Employees529.00
- LocationHOB Biotech Group Corp LtdNo. 9 Dongyanli Road, Industrial ParkSUZHOU 215009ChinaCHN
- Phone+86 51 269561996
- Fax+86 51 262956652
- Websitehttp://www.hob-biotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Chunlizhengda Mdicl Instr Co Ltd | 1.05bn | 255.37m | 7.81bn | 1.24k | 34.18 | 2.96 | -- | 7.41 | 0.6729 | 0.6729 | 2.78 | 7.78 | 0.2995 | 0.6437 | 3.48 | 851,792.40 | 7.26 | 9.44 | 8.55 | 11.52 | 64.99 | 72.15 | 24.23 | 25.01 | 5.09 | -- | 0.00007 | 24.89 | -33.32 | -1.18 | -55.01 | -11.99 | -17.97 | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.90bn | 143.32m | 8.01bn | 1.75k | 54.34 | 2.96 | -- | 4.21 | 0.258 | 0.258 | 3.43 | 4.74 | 0.4575 | 1.10 | 4.01 | 1,086,410.00 | 3.23 | 13.95 | 4.06 | 19.57 | 62.95 | 55.77 | 7.05 | 19.42 | 1.40 | 3.24 | 0.2714 | 33.21 | -2.02 | 18.05 | -15.06 | 22.90 | 35.88 | -- |
| HOB Biotech Group Corp Ltd | 387.48m | 36.43m | 9.03bn | 529.00 | 243.74 | 10.76 | -- | 23.31 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Shinva Medical Instrument Co Ltd | 9.58bn | 508.92m | 9.40bn | 8.14k | 18.52 | 1.20 | -- | 0.982 | 0.837 | 0.837 | 15.78 | 12.91 | 0.6286 | 2.20 | 4.50 | 1,177,051.00 | 3.30 | 4.12 | 6.27 | 8.97 | 24.46 | 25.09 | 5.24 | 5.61 | 0.8863 | -- | 0.124 | 21.15 | 0.0874 | 2.71 | 5.75 | -4.29 | 14.30 | 26.58 |
| Sino Medical Sciences Technology Inc | 504.11m | 29.36m | 9.54bn | 691.00 | 323.32 | 10.54 | -- | 18.92 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 9.66bn | 3.14k | -- | 2.31 | -- | 1.31 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 10.06bn | 2.16k | 28.71 | 1.94 | -- | 3.99 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Holder | Shares | % Held |
|---|---|---|
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2025 | 666.77k | 5.20% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 478.33k | 3.73% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 394.29k | 3.07% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 329.47k | 2.57% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 210.00k | 1.64% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2025 | 191.00k | 1.49% |
| Caitong Fund Management Co., Ltd.as of 30 Jun 2025 | 185.91k | 1.45% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 145.81k | 1.14% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 124.38k | 0.97% |
| China Post & Capital Fund Management Co., Ltd.as of 30 Jun 2025 | 116.63k | 0.91% |
